Neuroprotection Strategies in Preterm Encephalopathy

Semin Pediatr Neurol. 2019 Dec:32:100772. doi: 10.1016/j.spen.2019.08.008. Epub 2019 Aug 9.

Abstract

Advances in neonatology have led to unprecedented improvements in neonatal survival such that those born as early as 22 weeks of gestation now have some chance of survival, and over 70% of those born at 24 weeks of gestation survive. Up to 50% of infants born extremely preterm develop poor outcomes involving long-term neurodevelopmental impairments affecting cognition and learning, or motor problems such as cerebral palsy. Poor outcomes arise because the preterm brain is vulnerable both to direct injury (by events such as intracerebral hemorrhage, infection, and/or hypoxia), or indirect injury due to disruption of normal development. This neonatal brain injury and/or dysmaturation is called "encephalopathy of prematurity". Current and future strategies to improve outcomes in this population include prevention of preterm birth, and pre-, peri-, and postnatal approaches to protect the developing brain. This review will describe mechanisms of preterm brain injury, and current and upcoming therapies in the antepartum and postnatal period to improve preterm encephalopathy.

Publication types

  • Research Support, N.I.H., Extramural
  • Review

MeSH terms

  • Animals
  • Brain / drug effects
  • Brain / growth & development
  • Brain / physiopathology
  • Brain Diseases / physiopathology
  • Brain Diseases / therapy*
  • Female
  • Fetal Diseases / physiopathology
  • Fetal Diseases / therapy
  • Humans
  • Infant, Extremely Premature
  • Infant, Newborn
  • Neuroprotection
  • Pregnancy